Phoenix Financial Ltd. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 65.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,322 shares of the exchange traded fund’s stock after selling 10,200 shares during the period. Phoenix Financial Ltd.’s holdings in SPDR S&P Biotech ETF were worth $649,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Legacy Wealth Managment LLC ID bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $32,000. Ballast Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $36,000. Navalign LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $48,000. Barnes Dennig Private Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $48,000. Finally, Citizens National Bank Trust Department bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $50,000.
SPDR S&P Biotech ETF Price Performance
SPDR S&P Biotech ETF stock opened at $130.69 on Friday. The firm has a 50 day simple moving average of $129.38 and a 200-day simple moving average of $124.41. The stock has a market capitalization of $8.34 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12-month low of $77.33 and a 12-month high of $139.19.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
